Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where K.S. Maclean is active.

Publication


Featured researches published by K.S. Maclean.


The Lancet | 1973

LOW-DOSE UROKINASE IN MAJOR PULMONARY EMBOLISM

I.R. Edwards; K.S. Maclean; John Dow

Abstract Low-dose short-term urokinase was instilled directly into the pulmonary artery in nine consecutive patients with massive pulmonary embolism and shock. Seven patients showed dramatic clinical improvement, six with subsequent complete recovery. Two patients died from recurrent embolism, one after an initially satisfactory response and the other during therapy. A third patient died immediately before therapy.


The Lancet | 1968

TEN YEARS' EXPERIENCE OF STEROID ASSAYS IN THE MANAGEMENT OF BREAST CANCER: A Review

Hedley Atkins; R.D. Bulbrook; M.A. Falconer; J.L. Hayward; K.S. Maclean; P.H. Schurr

Abstract The usefulness of the discriminant function for the prediction of response to adrenalectomy or hypophysectomy has been investigated in 206 patients, over the past ten years. In general, patients with negative discriminants have a lower remission-rate than those with positive discriminants but factors such as the free period and menopausal status modify the predictive value of the discriminant. Patients without a previous mastectomy do not respond as well to adrenalectomy as they do to hypophysectomy. The combination of these clinical factors with the discriminant function affords a means of identifying a group of patients who are not responsive to endocrine ablation.


The Lancet | 1968

Ten years' experience of sterioid assays in the management of breast cancer. A review.

Hedley Atkins; R.D. Bulbrook; M.A. Falconer; J.L. Hayward; K.S. Maclean; P.H. Schurr


The Lancet | 1952

Isoniazid in pulmonary tuberculosis; its use with and without streptomycin.

C.L. Joiner; K.S. Maclean; E.K. Pritchard; Kevin Anderson; M.B. King; Patrick Collard; Robert Knox


The Lancet | 1957

Adrenalectomy and hypophysectomy for advanced cancer of the breast; a comparative study.

Hedley Atkins; M.A. Falconer; J.L. Hayward; K.S. Maclean


The Lancet | 1966

THE TIMING OF ADRENALECTOMY AND OF HYPOPHYSECTOMY IN THE TREATMENT OF ADVANCED BREAST CANCER

Hedley Atkins; M.A. Falconer; J.L. Hayward; K.S. Maclean; P.H. Schurr


The Lancet | 1964

URINARY STEROID ESTIMATIONS IN THE PREDICTION OF RESPONSE TO ADRENALECTOMY OR HYPOPHYSECTOMY

Hedley Atkins; R.D. Bulbrook; M.A. Falconer; J.L. Hayward; K.S. Maclean; P.H. Schurr


The Lancet | 1953

Chemotherapy of pulmonary tuberculosis

C.L. Joiner; K.S. Maclean; D.G. Chalmers; Kevin Anderson; M.B. King; Patrick Collard; Robert Knox


The Lancet | 1962

BUFFERED LOBELINE AS A SMOKING DETERRENT

G.W. Scott; A.G.C. Cox; K.S. Maclean; T.M.L. Price; N. Southwell


The Lancet | 1954

ISONIAZID AND P.A.S. IN CHRONIC PULMONARY TUBERCULOSIS A WARNING

C.L. Joiner; K.S. Maclean; J.D. Carroll; K. Marsh; Patrick Collard; Robert Knox

Collaboration


Dive into the K.S. Maclean's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge